GlassScriptPhysician profile
Jeanne Hershey-Weber
NPI 1386637643
$12,911.41
in general payments reported to CMS, 2019-2025
38 companies · $2,512 in 2025
The $2,512 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,496 · 2022: $2,337 · 2023: $3,139 · 2024: $3,428 · 2025: $2,512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,078.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $3,778.14 | 2021-2025 | Dovato, Cabenuva, Apretude |
| Gilead Sciences, INC. | $3,655.32 | 2021-2025 | Biktarvy, Veklury, Yeztugo |
| Merck Sharp & Dohme LLC | $848.23 | 2021-2025 | Pifeltro, Delstrigo, Capvaxive |
| Emd Serono, INC. | $673.08 | 2022-2025 | Serostim |
| Abbvie INC. | $391.74 | 2021-2025 | |
| Napo Pharmaceuticals INC | $322.75 | 2021-2025 | Mytesi |
| Theratechnologies INC. | $298.53 | 2022-2025 | Trogarzo, Egrifta |
| Janssen Biotech, INC. | $296.54 | 2021-2023 | Symtuza |
| Glaxosmithkline, LLC. | $217.52 | 2021-2024 | Arexvy, Shingrix |
| Lilly USA, LLC | $215.74 | 2021-2025 | Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $212.06 | 2022-2025 | Xifaxan |
| Antares Pharma, INC. | $172.65 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Janssen Pharmaceuticals, INC | $164.81 | 2025 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $151.48 | 2022 | |
| Alkermes, INC. | $136.95 | 2023-2024 | Lybalvi, Aristada |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanne Hershey-Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.